Actively Recruiting

Age: 0Years - 100Years
All Genders
Healthy Volunteers
NCT01970696

International Ovarian & Testicular Stromal Tumor Registry

Led by Children's Hospitals and Clinics of Minnesota · Updated on 2024-08-22

300

Participants Needed

1

Research Sites

990 weeks

Total Duration

On this page

Sponsors

C

Children's Hospitals and Clinics of Minnesota

Lead Sponsor

C

Children's National Research Institute

Collaborating Sponsor

AI-Summary

What this Trial Is About

Rare tumors are understudied, yet have the potential to shed light on vast areas of cancer research. Ovarian sex cord-stromal tumors, rare tumors of childhood and young adulthood, have recently been found to be associated with a lung cancer of early childhood called pleuropulmonary blastoma (PPB). The cause of these ovarian tumors is unknown. DICER1 mutations are seen in the majority of children with PPB. Research shows DICER1 mutations are also seen in some patients with ovarian tumors. Like PPB, ovarian stromal tumors are highly curable when found in early stage; however, later forms of the disease are aggressive and often fatal. The International Ovarian Stromal Tumor Registry collects clinical and biologic data to understand why these tumors occur and how to treat them. Current work involves the study of the role of DICER1 and miRNA expression in ovarian stromal tumors. Understanding the clinical history, predisposing factors and DICER1 and miRNA expression in these ovarian tumors of childhood will lead to targeted screening and risk stratification for evidence-based treatment and biologically rational therapies. These efforts will improve the lives of children by increasing survival and reducing late effects. The specific goals of the International Ovarian and Testicular Stromal Tumor Registry are: 1. to understand risk factors by studying age, pathologic subtype, histopathologic features, tumor invasiveness, degree of differentiation, presence of metastasis 2. to collect information on personal and family history in order to refine the clinical characteristics of patients and families with and without germline DICER1 mutations and other genetic predisposing factors 3. to determine whether there is a pattern of gene expression or DNA alterations that correlate with predisposition to ovarian tumors, biologic behavior and clinical outcome 4. to determine optimal screening regimens 5. to use clinical data obtained through the Registry to refine treatment algorithms 6. to establish a collection of annotated biology specimens (tumor tissue and germline DNA) for future research

CONDITIONS

Official Title

International Ovarian & Testicular Stromal Tumor Registry

Who Can Participate

Age: 0Years - 100Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Previous or current diagnosis of an ovarian sex cord stromal tumor including but not limited to Sertoli-Leydig cell tumor, gynandroblastoma, juvenile granulosa cell tumor, Sertoli cell tumor, sex cord-stromal tumor with annular tubules, or undifferentiated stromal tumor
  • Previous or current diagnosis of a testicular stromal tumor including but not limited to juvenile granulosa cell tumor, Sertoli cell tumor, Leydig cell tumor, or undifferentiated stromal tumor
Not Eligible

You will not qualify if you...

  • Unable to provide informed consent or assent
  • Adult granulosa cell tumor (unless otherwise specified by Medical Director)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Children's Minnesota

Minneapolis, Minnesota, United States, 55404

Actively Recruiting

Loading map...

Research Team

A

Anne Harris, MPH

CONTACT

P

Paige Mallinger, MS

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here